MétaCan
Menu
Back to cohort

PTU-035 Economic impact of non-response to ursodeoxycholic acid in primary biliary cholangitis patients

2019· article· en· W2954320912 on OpenAlexaboutno aff
Parivrudh Sharma, Lynne Crighton, Balasubramaniam Vijayan, Shirley English, Ashis Mukhopadhya

Bibliographic record

Venuenot available
Typearticle
Languageen
FieldMedicine
TopicLiver Diseases and Immunity
Canadian institutionsnot available
Fundersnot available
KeywordsUrsodeoxycholic acidMedicineInternal medicineGastroenterologyCreatinineBilirubinCohortAlkaline phosphatase

Abstract

fetched live from OpenAlex

Introduction NICE recommends the use of Obeticholic acid (OCA), as a second-line treatment for failed or intolerant ursodeoxycholic acid (UDCA) drug therapy in primary biliary cholangitis (PBC). This audit aims to determine the proportion of PBC patients, in a tertiary referral hospital experiencing failed UDCA drug therapy, to gauge the potential economic impact of a switch to OCA. Methods A total of 120 patients with PBC were identified from an existing patient database. 24 patients were excluded due to inappropriate diagnosis, missing data, non-attendance or failure to tolerate UDCA. Baseline characteristics, UDCA dosage and biochemical response were recorded for all patients. For the purpose of this study, failed UDCA drug therapy was defined as an alkaline phosphatase (ALP) level of greater than 1.67 times the upper limit of normal (ULN) (Toronto Criteria)1. Results Of the 96 patients included for analysis, 9 were male and the remaining 87 were female. The mean age and weight were 64.4± 11.9 years and 75.9± 15.4 kg respectively. The mean blood results for haemoglobin, platelets, bilirubin, ALP, alanine aminotransferase, and creatinine were 126.8± 15.0 g/L, 254.5± 94.3 x10^9/L, 9.4± 4.3 µmol/L, 144.4± 75.6 u/L, 30.3± 19.3 u/L, and 75.1± 28.3 µmol/L respectively. The mean UDCA dose for the cohort was 13.9± 5.9 mg/kg/day. Biochemical failure was documented in 13 patients who had an ALP of greater than 1.67 times the ULN at the end of 1 year of therapy with UDCA (13.5%). Of these 13 patients, 4 were found to be on suboptimal dosage of UDCA (<10 mg/kg/day), leading to a true non-response rate in 9/96 subjects (9.4%). Conclusions A substantial proportion of PBC patients were found to be biochemically unresponsive to UDCA. Shifting these patients to OCA would lead to significant drug expenditure for NHS Grampian. An intermediary step of shifting non-responsive patients to the cheaper drug, Bezafibrate, may prove to be cost-effective, but this drug has been revealed to have no benefit in a recent Cochrane review2. References Kumagi T, Guindi M, Fischer SE, et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol 2010; 105: 2186–2194. Rudic JS, Poropat G, Krstic MN, Bjelakovic G, Gluud C. Bezafibrate for primary biliary cirrhosis. Cochrane Database of Systematic Reviews 2012, Issue 1. Art. No.: CD009145.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.011
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.024

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.011
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.002
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.272
Teacher spread0.265 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same topicLiver Diseases and ImmunityFrench-language works237,207